Literature DB >> 2648929

Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms.

B Lo1, R L Steinbrook, M Cooke, T J Coates, E J Walters, S B Hulley.   

Abstract

Voluntary screening for human immunodeficiency virus (HIV) infection may help prevent the spread of the HIV epidemic if persons who test positive alter behaviors that may transmit infection. Protecting persons from unknowingly being exposed to HIV infection must be balanced against respecting the autonomy of individuals being screened. Seropositive patients may feel a stigma and be subjected to discrimination if confidentiality of test results is breached. In patients without high-risk behaviors, the positive predictive value of HIV testing may be substantially increased if tests are done in reference laboratories and if further confirmatory tests are run on a second blood specimen. For persons with high-risk behaviors, HIV testing can be recommended to those who want to reduce uncertainty about their HIV status or whose medical care would change if they were seropositive. Health care workers can maximize benefits of screening and minimize harm by educating and counseling patients before HIV testing, discussing the confidentiality of HIV test results, urging patients to disclose positive test results to sex partners, and advising patients on how to reduce high-risk behaviors.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  1989        PMID: 2648929     DOI: 10.7326/0003-4819-110-9-727

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

Review 1.  Ethical problems raised by anti-HIV vaccination.

Authors:  P Enel; J Charrel; M P Larher; D Reviron; C Manuel; J L San Marco
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 2.  AIDS, a social dilemma: detection of seropositives.

Authors:  P Enel; C Manuel; J Charrel; M P Larher; D Reviron; J L San Marco
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Cuba's response to the HIV epidemic.

Authors:  E J Pérez-Stable
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

Review 4.  Assessing HIV infection in primary care practice.

Authors:  H J Makadon
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

5.  A retrospective analysis of the prevalence of HIV seropositivity and its demographics in the normal healthy volunteer population of a phase-I clinical drug study unit.

Authors:  R Jagathesan; L D Lewis; T G Mant
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 6.  Monitoring the prevalence of HIV.

Authors:  O N Gill; M W Adler; N E Day
Journal:  BMJ       Date:  1989-11-25

7.  Perspectives on medical research involving men in schizophrenia and HIV-related protocols.

Authors:  Laura Weiss Roberts; Teddy D Warner; Katherine A Green Hammond; Cynthia M A Geppert
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

8.  Counselling and testing for HIV infection in Rome 1985-1990: analysis of client characteristics and seroprevalence.

Authors:  E Girardi; V Puro; M Colaiacomo; E Lo Presti; D Frigiotti; V Giannini; G Visco; G Ippolito
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

Review 9.  Counseling patients seropositive for human immunodeficiency virus. An approach for medical practice.

Authors:  T J Coates; B Lo
Journal:  West J Med       Date:  1990-12

10.  Prevalence of human immunodeficiency virus risk factors in patients attending an accident and emergency department.

Authors:  M Doyle; R J Taylor
Journal:  Arch Emerg Med       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.